- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
According to our latest study, the global Liposomes for Drug Delivery market size was valued at USD 3431.8 million in 2022 and is forecast to a readjusted size of USD 4211.1 million by 2029 with a CAGR of 3.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominated the market with market share of 44% due to the high medical level. Following North America, Europe is the second largest market with market share of 36%. Asian Pacific regions are the third largest market with developed countries like Japan and many developing countries like China. Its market share is about 12%.
Johnson & Johnson, Gilead Sciences, Pacira, Sun Pharmaceutical, Luye Pharma and Sigma-Tau Group are the top 6 players of Liposomes Drug Delivery, with about 77% market shares.
This report is a detailed and comprehensive analysis for global Liposomes for Drug Delivery market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Liposomes for Drug Delivery market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2018-2029
Global Liposomes for Drug Delivery market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2018-2029
Global Liposomes for Drug Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2018-2029
Global Liposomes for Drug Delivery market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liposomes for Drug Delivery
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liposomes for Drug Delivery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lipoid Kosmetik, Lucas Meyer Cosmetics, Nippon Fine Chemical, Enoc Solutions and Nanovec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Liposomes for Drug Delivery market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liposome Vitamin
Liposome Ceramide
Liposome CoQ10
Others
Market segment by Application
Hydrophilic Drugs
Hydrophobic Drugs
Major players covered
Lipoid Kosmetik
Lucas Meyer Cosmetics
Nippon Fine Chemical
Enoc Solutions
Nanovec
Lipotec
Croda
H&A Pharmachem
Lipomize
ID bio
BioSpectrum
Derma Clinical
Kewpie Corporation
Nanohealth Biotech
Creative Biostructure
Phenbiox
NOF CORPORATION
KYOWA PHARMA CHEMICAL
Nikko Chemicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposomes for Drug Delivery product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Liposomes for Drug Delivery, with price, sales, revenue and global market share of Liposomes for Drug Delivery from 2018 to 2023.
Chapter 3, the Liposomes for Drug Delivery competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposomes for Drug Delivery breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Liposomes for Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Liposomes for Drug Delivery.
Chapter 14 and 15, to describe Liposomes for Drug Delivery sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Liposomes for Drug Delivery
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Liposomes for Drug Delivery Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Liposome Vitamin
1.3.3 Liposome Ceramide
1.3.4 Liposome CoQ10
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Liposomes for Drug Delivery Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hydrophilic Drugs
1.4.3 Hydrophobic Drugs
1.5 Global Liposomes for Drug Delivery Market Size & Forecast
1.5.1 Global Liposomes for Drug Delivery Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Liposomes for Drug Delivery Sales Quantity (2018-2029)
1.5.3 Global Liposomes for Drug Delivery Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Lipoid Kosmetik
2.1.1 Lipoid Kosmetik Details
2.1.2 Lipoid Kosmetik Major Business
2.1.3 Lipoid Kosmetik Liposomes for Drug Delivery Product and Services
2.1.4 Lipoid Kosmetik Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lipoid Kosmetik Recent Developments/Updates
2.2 Lucas Meyer Cosmetics
2.2.1 Lucas Meyer Cosmetics Details
2.2.2 Lucas Meyer Cosmetics Major Business
2.2.3 Lucas Meyer Cosmetics Liposomes for Drug Delivery Product and Services
2.2.4 Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Lucas Meyer Cosmetics Recent Developments/Updates
2.3 Nippon Fine Chemical
2.3.1 Nippon Fine Chemical Details
2.3.2 Nippon Fine Chemical Major Business
2.3.3 Nippon Fine Chemical Liposomes for Drug Delivery Product and Services
2.3.4 Nippon Fine Chemical Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Nippon Fine Chemical Recent Developments/Updates
2.4 Enoc Solutions
2.4.1 Enoc Solutions Details
2.4.2 Enoc Solutions Major Business
2.4.3 Enoc Solutions Liposomes for Drug Delivery Product and Services
2.4.4 Enoc Solutions Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Enoc Solutions Recent Developments/Updates
2.5 Nanovec
2.5.1 Nanovec Details
2.5.2 Nanovec Major Business
2.5.3 Nanovec Liposomes for Drug Delivery Product and Services
2.5.4 Nanovec Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nanovec Recent Developments/Updates
2.6 Lipotec
2.6.1 Lipotec Details
2.6.2 Lipotec Major Business
2.6.3 Lipotec Liposomes for Drug Delivery Product and Services
2.6.4 Lipotec Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lipotec Recent Developments/Updates
2.7 Croda
2.7.1 Croda Details
2.7.2 Croda Major Business
2.7.3 Croda Liposomes for Drug Delivery Product and Services
2.7.4 Croda Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Croda Recent Developments/Updates
2.8 H&A Pharmachem
2.8.1 H&A Pharmachem Details
2.8.2 H&A Pharmachem Major Business
2.8.3 H&A Pharmachem Liposomes for Drug Delivery Product and Services
2.8.4 H&A Pharmachem Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 H&A Pharmachem Recent Developments/Updates
2.9 Lipomize
2.9.1 Lipomize Details
2.9.2 Lipomize Major Business
2.9.3 Lipomize Liposomes for Drug Delivery Product and Services
2.9.4 Lipomize Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lipomize Recent Developments/Updates
2.10 ID bio
2.10.1 ID bio Details
2.10.2 ID bio Major Business
2.10.3 ID bio Liposomes for Drug Delivery Product and Services
2.10.4 ID bio Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ID bio Recent Developments/Updates
2.11 BioSpectrum
2.11.1 BioSpectrum Details
2.11.2 BioSpectrum Major Business
2.11.3 BioSpectrum Liposomes for Drug Delivery Product and Services
2.11.4 BioSpectrum Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioSpectrum Recent Developments/Updates
2.12 Derma Clinical
2.12.1 Derma Clinical Details
2.12.2 Derma Clinical Major Business
2.12.3 Derma Clinical Liposomes for Drug Delivery Product and Services
2.12.4 Derma Clinical Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Derma Clinical Recent Developments/Updates
2.13 Kewpie Corporation
2.13.1 Kewpie Corporation Details
2.13.2 Kewpie Corporation Major Business
2.13.3 Kewpie Corporation Liposomes for Drug Delivery Product and Services
2.13.4 Kewpie Corporation Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Kewpie Corporation Recent Developments/Updates
2.14 Nanohealth Biotech
2.14.1 Nanohealth Biotech Details
2.14.2 Nanohealth Biotech Major Business
2.14.3 Nanohealth Biotech Liposomes for Drug Delivery Product and Services
2.14.4 Nanohealth Biotech Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nanohealth Biotech Recent Developments/Updates
2.15 Creative Biostructure
2.15.1 Creative Biostructure Details
2.15.2 Creative Biostructure Major Business
2.15.3 Creative Biostructure Liposomes for Drug Delivery Product and Services
2.15.4 Creative Biostructure Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Creative Biostructure Recent Developments/Updates
2.16 Phenbiox
2.16.1 Phenbiox Details
2.16.2 Phenbiox Major Business
2.16.3 Phenbiox Liposomes for Drug Delivery Product and Services
2.16.4 Phenbiox Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Phenbiox Recent Developments/Updates
2.17 NOF CORPORATION
2.17.1 NOF CORPORATION Details
2.17.2 NOF CORPORATION Major Business
2.17.3 NOF CORPORATION Liposomes for Drug Delivery Product and Services
2.17.4 NOF CORPORATION Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 NOF CORPORATION Recent Developments/Updates
2.18 KYOWA PHARMA CHEMICAL
2.18.1 KYOWA PHARMA CHEMICAL Details
2.18.2 KYOWA PHARMA CHEMICAL Major Business
2.18.3 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product and Services
2.18.4 KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 KYOWA PHARMA CHEMICAL Recent Developments/Updates
2.19 Nikko Chemicals
2.19.1 Nikko Chemicals Details
2.19.2 Nikko Chemicals Major Business
2.19.3 Nikko Chemicals Liposomes for Drug Delivery Product and Services
2.19.4 Nikko Chemicals Liposomes for Drug Delivery Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Nikko Chemicals Recent Developments/Updates
3 Competitive Environment: Liposomes for Drug Delivery by Manufacturer
3.1 Global Liposomes for Drug Delivery Sales Quantity by Manufacturer (2018-2023)
3.2 Global Liposomes for Drug Delivery Revenue by Manufacturer (2018-2023)
3.3 Global Liposomes for Drug Delivery Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Liposomes for Drug Delivery by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Liposomes for Drug Delivery Manufacturer Market Share in 2022
3.4.2 Top 6 Liposomes for Drug Delivery Manufacturer Market Share in 2022
3.5 Liposomes for Drug Delivery Market: Overall Company Footprint Analysis
3.5.1 Liposomes for Drug Delivery Market: Region Footprint
3.5.2 Liposomes for Drug Delivery Market: Company Product Type Footprint
3.5.3 Liposomes for Drug Delivery Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Liposomes for Drug Delivery Market Size by Region
4.1.1 Global Liposomes for Drug Delivery Sales Quantity by Region (2018-2029)
4.1.2 Global Liposomes for Drug Delivery Consumption Value by Region (2018-2029)
4.1.3 Global Liposomes for Drug Delivery Average Price by Region (2018-2029)
4.2 North America Liposomes for Drug Delivery Consumption Value (2018-2029)
4.3 Europe Liposomes for Drug Delivery Consumption Value (2018-2029)
4.4 Asia-Pacific Liposomes for Drug Delivery Consumption Value (2018-2029)
4.5 South America Liposomes for Drug Delivery Consumption Value (2018-2029)
4.6 Middle East and Africa Liposomes for Drug Delivery Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Liposomes for Drug Delivery Sales Quantity by Type (2018-2029)
5.2 Global Liposomes for Drug Delivery Consumption Value by Type (2018-2029)
5.3 Global Liposomes for Drug Delivery Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Liposomes for Drug Delivery Sales Quantity by Application (2018-2029)
6.2 Global Liposomes for Drug Delivery Consumption Value by Application (2018-2029)
6.3 Global Liposomes for Drug Delivery Average Price by Application (2018-2029)
7 North America
7.1 North America Liposomes for Drug Delivery Sales Quantity by Type (2018-2029)
7.2 North America Liposomes for Drug Delivery Sales Quantity by Application (2018-2029)
7.3 North America Liposomes for Drug Delivery Market Size by Country
7.3.1 North America Liposomes for Drug Delivery Sales Quantity by Country (2018-2029)
7.3.2 North America Liposomes for Drug Delivery Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Liposomes for Drug Delivery Sales Quantity by Type (2018-2029)
8.2 Europe Liposomes for Drug Delivery Sales Quantity by Application (2018-2029)
8.3 Europe Liposomes for Drug Delivery Market Size by Country
8.3.1 Europe Liposomes for Drug Delivery Sales Quantity by Country (2018-2029)
8.3.2 Europe Liposomes for Drug Delivery Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Liposomes for Drug Delivery Market Size by Region
9.3.1 Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Liposomes for Drug Delivery Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Liposomes for Drug Delivery Sales Quantity by Type (2018-2029)
10.2 South America Liposomes for Drug Delivery Sales Quantity by Application (2018-2029)
10.3 South America Liposomes for Drug Delivery Market Size by Country
10.3.1 South America Liposomes for Drug Delivery Sales Quantity by Country (2018-2029)
10.3.2 South America Liposomes for Drug Delivery Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Liposomes for Drug Delivery Market Size by Country
11.3.1 Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Liposomes for Drug Delivery Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Liposomes for Drug Delivery Market Drivers
12.2 Liposomes for Drug Delivery Market Restraints
12.3 Liposomes for Drug Delivery Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Liposomes for Drug Delivery and Key Manufacturers
13.2 Manufacturing Costs Percentage of Liposomes for Drug Delivery
13.3 Liposomes for Drug Delivery Production Process
13.4 Liposomes for Drug Delivery Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Liposomes for Drug Delivery Typical Distributors
14.3 Liposomes for Drug Delivery Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Liposomes for Drug Delivery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Liposomes for Drug Delivery Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Lipoid Kosmetik Basic Information, Manufacturing Base and Competitors
Table 4. Lipoid Kosmetik Major Business
Table 5. Lipoid Kosmetik Liposomes for Drug Delivery Product and Services
Table 6. Lipoid Kosmetik Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Lipoid Kosmetik Recent Developments/Updates
Table 8. Lucas Meyer Cosmetics Basic Information, Manufacturing Base and Competitors
Table 9. Lucas Meyer Cosmetics Major Business
Table 10. Lucas Meyer Cosmetics Liposomes for Drug Delivery Product and Services
Table 11. Lucas Meyer Cosmetics Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Lucas Meyer Cosmetics Recent Developments/Updates
Table 13. Nippon Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 14. Nippon Fine Chemical Major Business
Table 15. Nippon Fine Chemical Liposomes for Drug Delivery Product and Services
Table 16. Nippon Fine Chemical Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Nippon Fine Chemical Recent Developments/Updates
Table 18. Enoc Solutions Basic Information, Manufacturing Base and Competitors
Table 19. Enoc Solutions Major Business
Table 20. Enoc Solutions Liposomes for Drug Delivery Product and Services
Table 21. Enoc Solutions Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Enoc Solutions Recent Developments/Updates
Table 23. Nanovec Basic Information, Manufacturing Base and Competitors
Table 24. Nanovec Major Business
Table 25. Nanovec Liposomes for Drug Delivery Product and Services
Table 26. Nanovec Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Nanovec Recent Developments/Updates
Table 28. Lipotec Basic Information, Manufacturing Base and Competitors
Table 29. Lipotec Major Business
Table 30. Lipotec Liposomes for Drug Delivery Product and Services
Table 31. Lipotec Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lipotec Recent Developments/Updates
Table 33. Croda Basic Information, Manufacturing Base and Competitors
Table 34. Croda Major Business
Table 35. Croda Liposomes for Drug Delivery Product and Services
Table 36. Croda Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Croda Recent Developments/Updates
Table 38. H&A Pharmachem Basic Information, Manufacturing Base and Competitors
Table 39. H&A Pharmachem Major Business
Table 40. H&A Pharmachem Liposomes for Drug Delivery Product and Services
Table 41. H&A Pharmachem Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. H&A Pharmachem Recent Developments/Updates
Table 43. Lipomize Basic Information, Manufacturing Base and Competitors
Table 44. Lipomize Major Business
Table 45. Lipomize Liposomes for Drug Delivery Product and Services
Table 46. Lipomize Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Lipomize Recent Developments/Updates
Table 48. ID bio Basic Information, Manufacturing Base and Competitors
Table 49. ID bio Major Business
Table 50. ID bio Liposomes for Drug Delivery Product and Services
Table 51. ID bio Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. ID bio Recent Developments/Updates
Table 53. BioSpectrum Basic Information, Manufacturing Base and Competitors
Table 54. BioSpectrum Major Business
Table 55. BioSpectrum Liposomes for Drug Delivery Product and Services
Table 56. BioSpectrum Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. BioSpectrum Recent Developments/Updates
Table 58. Derma Clinical Basic Information, Manufacturing Base and Competitors
Table 59. Derma Clinical Major Business
Table 60. Derma Clinical Liposomes for Drug Delivery Product and Services
Table 61. Derma Clinical Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Derma Clinical Recent Developments/Updates
Table 63. Kewpie Corporation Basic Information, Manufacturing Base and Competitors
Table 64. Kewpie Corporation Major Business
Table 65. Kewpie Corporation Liposomes for Drug Delivery Product and Services
Table 66. Kewpie Corporation Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Kewpie Corporation Recent Developments/Updates
Table 68. Nanohealth Biotech Basic Information, Manufacturing Base and Competitors
Table 69. Nanohealth Biotech Major Business
Table 70. Nanohealth Biotech Liposomes for Drug Delivery Product and Services
Table 71. Nanohealth Biotech Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Nanohealth Biotech Recent Developments/Updates
Table 73. Creative Biostructure Basic Information, Manufacturing Base and Competitors
Table 74. Creative Biostructure Major Business
Table 75. Creative Biostructure Liposomes for Drug Delivery Product and Services
Table 76. Creative Biostructure Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Creative Biostructure Recent Developments/Updates
Table 78. Phenbiox Basic Information, Manufacturing Base and Competitors
Table 79. Phenbiox Major Business
Table 80. Phenbiox Liposomes for Drug Delivery Product and Services
Table 81. Phenbiox Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Phenbiox Recent Developments/Updates
Table 83. NOF CORPORATION Basic Information, Manufacturing Base and Competitors
Table 84. NOF CORPORATION Major Business
Table 85. NOF CORPORATION Liposomes for Drug Delivery Product and Services
Table 86. NOF CORPORATION Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. NOF CORPORATION Recent Developments/Updates
Table 88. KYOWA PHARMA CHEMICAL Basic Information, Manufacturing Base and Competitors
Table 89. KYOWA PHARMA CHEMICAL Major Business
Table 90. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Product and Services
Table 91. KYOWA PHARMA CHEMICAL Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. KYOWA PHARMA CHEMICAL Recent Developments/Updates
Table 93. Nikko Chemicals Basic Information, Manufacturing Base and Competitors
Table 94. Nikko Chemicals Major Business
Table 95. Nikko Chemicals Liposomes for Drug Delivery Product and Services
Table 96. Nikko Chemicals Liposomes for Drug Delivery Sales Quantity (Tons), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Nikko Chemicals Recent Developments/Updates
Table 98. Global Liposomes for Drug Delivery Sales Quantity by Manufacturer (2018-2023) & (Tons)
Table 99. Global Liposomes for Drug Delivery Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Liposomes for Drug Delivery Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 101. Market Position of Manufacturers in Liposomes for Drug Delivery, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Liposomes for Drug Delivery Production Site of Key Manufacturer
Table 103. Liposomes for Drug Delivery Market: Company Product Type Footprint
Table 104. Liposomes for Drug Delivery Market: Company Product Application Footprint
Table 105. Liposomes for Drug Delivery New Market Entrants and Barriers to Market Entry
Table 106. Liposomes for Drug Delivery Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Liposomes for Drug Delivery Sales Quantity by Region (2018-2023) & (Tons)
Table 108. Global Liposomes for Drug Delivery Sales Quantity by Region (2024-2029) & (Tons)
Table 109. Global Liposomes for Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Liposomes for Drug Delivery Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Liposomes for Drug Delivery Average Price by Region (2018-2023) & (US$/Kg)
Table 112. Global Liposomes for Drug Delivery Average Price by Region (2024-2029) & (US$/Kg)
Table 113. Global Liposomes for Drug Delivery Sales Quantity by Type (2018-2023) & (Tons)
Table 114. Global Liposomes for Drug Delivery Sales Quantity by Type (2024-2029) & (Tons)
Table 115. Global Liposomes for Drug Delivery Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Liposomes for Drug Delivery Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Liposomes for Drug Delivery Average Price by Type (2018-2023) & (US$/Kg)
Table 118. Global Liposomes for Drug Delivery Average Price by Type (2024-2029) & (US$/Kg)
Table 119. Global Liposomes for Drug Delivery Sales Quantity by Application (2018-2023) & (Tons)
Table 120. Global Liposomes for Drug Delivery Sales Quantity by Application (2024-2029) & (Tons)
Table 121. Global Liposomes for Drug Delivery Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Liposomes for Drug Delivery Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Liposomes for Drug Delivery Average Price by Application (2018-2023) & (US$/Kg)
Table 124. Global Liposomes for Drug Delivery Average Price by Application (2024-2029) & (US$/Kg)
Table 125. North America Liposomes for Drug Delivery Sales Quantity by Type (2018-2023) & (Tons)
Table 126. North America Liposomes for Drug Delivery Sales Quantity by Type (2024-2029) & (Tons)
Table 127. North America Liposomes for Drug Delivery Sales Quantity by Application (2018-2023) & (Tons)
Table 128. North America Liposomes for Drug Delivery Sales Quantity by Application (2024-2029) & (Tons)
Table 129. North America Liposomes for Drug Delivery Sales Quantity by Country (2018-2023) & (Tons)
Table 130. North America Liposomes for Drug Delivery Sales Quantity by Country (2024-2029) & (Tons)
Table 131. North America Liposomes for Drug Delivery Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Liposomes for Drug Delivery Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Liposomes for Drug Delivery Sales Quantity by Type (2018-2023) & (Tons)
Table 134. Europe Liposomes for Drug Delivery Sales Quantity by Type (2024-2029) & (Tons)
Table 135. Europe Liposomes for Drug Delivery Sales Quantity by Application (2018-2023) & (Tons)
Table 136. Europe Liposomes for Drug Delivery Sales Quantity by Application (2024-2029) & (Tons)
Table 137. Europe Liposomes for Drug Delivery Sales Quantity by Country (2018-2023) & (Tons)
Table 138. Europe Liposomes for Drug Delivery Sales Quantity by Country (2024-2029) & (Tons)
Table 139. Europe Liposomes for Drug Delivery Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Liposomes for Drug Delivery Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Type (2018-2023) & (Tons)
Table 142. Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Type (2024-2029) & (Tons)
Table 143. Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Application (2018-2023) & (Tons)
Table 144. Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Application (2024-2029) & (Tons)
Table 145. Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Region (2018-2023) & (Tons)
Table 146. Asia-Pacific Liposomes for Drug Delivery Sales Quantity by Region (2024-2029) & (Tons)
Table 147. Asia-Pacific Liposomes for Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Liposomes for Drug Delivery Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Liposomes for Drug Delivery Sales Quantity by Type (2018-2023) & (Tons)
Table 150. South America Liposomes for Drug Delivery Sales Quantity by Type (2024-2029) & (Tons)
Table 151. South America Liposomes for Drug Delivery Sales Quantity by Application (2018-2023) & (Tons)
Table 152. South America Liposomes for Drug Delivery Sales Quantity by Application (2024-2029) & (Tons)
Table 153. South America Liposomes for Drug Delivery Sales Quantity by Country (2018-2023) & (Tons)
Table 154. South America Liposomes for Drug Delivery Sales Quantity by Country (2024-2029) & (Tons)
Table 155. South America Liposomes for Drug Delivery Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Liposomes for Drug Delivery Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Type (2018-2023) & (Tons)
Table 158. Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Type (2024-2029) & (Tons)
Table 159. Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Application (2018-2023) & (Tons)
Table 160. Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Application (2024-2029) & (Tons)
Table 161. Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Region (2018-2023) & (Tons)
Table 162. Middle East & Africa Liposomes for Drug Delivery Sales Quantity by Region (2024-2029) & (Tons)
Table 163. Middle East & Africa Liposomes for Drug Delivery Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Liposomes for Drug Delivery Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Liposomes for Drug Delivery Raw Material
Table 166. Key Manufacturers of Liposomes for Drug Delivery Raw Materials
Table 167. Liposomes for Drug Delivery Typical Distributors
Table 168. Liposomes for Drug Delivery Typical Customers
List of Figures
Figure 1. Liposomes for Drug Delivery Picture
Figure 2. Global Liposomes for Drug Delivery Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Liposomes for Drug Delivery Consumption Value Market Share by Type in 2022
Figure 4. Liposome Vitamin Examples
Figure 5. Liposome Ceramide Examples
Figure 6. Liposome CoQ10 Examples
Figure 7. Others Examples
Figure 8. Global Liposomes for Drug Delivery Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Liposomes for Drug Delivery Consumption Value Market Share by Application in 2022
Figure 10. Hydrophilic Drugs Examples
Figure 11. Hydrophobic Drugs Examples
Figure 12. Global Liposomes for Drug Delivery Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Liposomes for Drug Delivery Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Liposomes for Drug Delivery Sales Quantity (2018-2029) & (Tons)
Figure 15. Global Liposomes for Drug Delivery Average Price (2018-2029) & (US$/Kg)
Figure 16. Global Liposomes for Drug Delivery Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Liposomes for Drug Delivery Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Liposomes for Drug Delivery by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Liposomes for Drug Delivery Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Liposomes for Drug Delivery Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Liposomes for Drug Delivery Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Liposomes for Drug Delivery Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Liposomes for Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Liposomes for Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Liposomes for Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Liposomes for Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Liposomes for Drug Delivery Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Liposomes for Drug Delivery Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Liposomes for Drug Delivery Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Liposomes for Drug Delivery Average Price by Type (2018-2029) & (US$/Kg)
Figure 31. Global Liposomes for Drug Delivery Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Liposomes for Drug Delivery Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Liposomes for Drug Delivery Average Price by Application (2018-2029) & (US$/Kg)
Figure 34. North America Liposomes for Drug Delivery Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Liposomes for Drug Delivery Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Liposomes for Drug Delivery Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Liposomes for Drug Delivery Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Liposomes for Drug Delivery Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Liposomes for Drug Delivery Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Liposomes for Drug Delivery Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Liposomes for Drug Delivery Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Liposomes for Drug Delivery Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Liposomes for Drug Delivery Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Liposomes for Drug Delivery Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Liposomes for Drug Delivery Consumption Value Market Share by Region (2018-2029)
Figure 54. China Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Liposomes for Drug Delivery Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Liposomes for Drug Delivery Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Liposomes for Drug Delivery Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Liposomes for Drug Delivery Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Liposomes for Drug Delivery Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Liposomes for Drug Delivery Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Liposomes for Drug Delivery Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Liposomes for Drug Delivery Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Liposomes for Drug Delivery Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Liposomes for Drug Delivery Market Drivers
Figure 75. Liposomes for Drug Delivery Market Restraints
Figure 76. Liposomes for Drug Delivery Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Liposomes for Drug Delivery in 2022
Figure 79. Manufacturing Process Analysis of Liposomes for Drug Delivery
Figure 80. Liposomes for Drug Delivery Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
